Breaking News

Yesterday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	Bio-Techne's Exosome Diagnostics laboratory announces contract with Humana » 07:05 03/01/21 03/01 07:05 03/01/21 07:05 TECH Bio-Techne $362.00 / -5.49 (-1.49%) , HUM Humana $379.64 / -1.3 (-0.34%) Bio-Techne (TECH)… Bio-Techne (TECH) announced that Humana (HUM) has awarded a contract effective April 1, to its Exosome Diagnostics laboratory, covering the ExoDx Prostate test for men. Humana is the nation's largest Medicare Advantage provider serving an estimated 20M patients in the United States. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TECH HUM TECH Bio-Techne $362.00 / -5.49 (-1.49%) 02/23/21 Bio-Techne, Luminary Therapeutics sign license agreement for us of TcBuster 02/08/21 Kantaro Biosciences signs marketing and distribution agreement with Atrys 01/28/21 Bio-Techne announces strategic investment in Eminence 12/02/20 Bio-Techne and Regulus collaborate in biomarker development HUM Humana $379.64 / -1.3 (-0.34%) 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/11/21 Humana, IBM Watson announce collaboration using artificial intelligence 02/03/21 Humana CEO sees 'solid growth in 2021 and beyond' 01/29/21 Humana selected by OHCA to deliver coverage to Medicaid beneficiaries TECH HUM TECH Bio-Techne $362.00 / -5.49 (-1.49%) 02/23/21 Stifel Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance 02/23/21 Stifel Bio-Techne upgraded to Buy from Hold at Stifel 02/03/21 Craig-Hallum Bio-Techne price target raised to $440 from $352 at Craig-Hallum 02/03/21 Citi Bio-Techne price target raised to $400 from $310 at Citi HUM Humana $379.64 / -1.3 (-0.34%) 01/13/21 Deutsche Bank DaVita price target raised to $150 from $105 at Deutsche Bank 01/06/21 Argus Humana price target raised to $450 from $430 at Argus 01/04/21 Fly Intel: Top five analyst upgrades 01/04/21 Humana upgraded to Outperform at RBC Capital on above-average MA growth TECH HUM TECH Bio-Techne $362.00 / -5.49 (-1.49%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09 HUM Humana $379.64 / -1.3 (-0.34%) 02/03/21 Humana reports Q4 adjusted revenue $18.96B, consensus $18.77B 02/03/21 Humana sees FY21 adjusted EPS $21.25-$21.75, consensus $21.73 02/03/21 Humana reports Q4 adjusted EPS ($2.30), consensus ($2.36) 02/02/21 Notable companies reporting before tomorrow's open HUM HUM Humana $379.64 / -1.3 (-0.34%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says HUM HUM Humana $379.64 / -1.3 (-0.34%) 02/03/21 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: What to watch in Salesforce's earnings report 11/14/20 Week in review: How Trump's policies moved stocks 09/01/20 Fly Intel: Wall Street's top stories for Tuesday 00:00 Today 41st Annual Healthcare Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 10/06/21 Humana

Thursday
Conference/Events	Citigroup to hold a virtual conference » 04:55 02/25/21 02/25 04:55 02/25/21 04:55 BIO Bio-Rad $594.44 / +0.09 (+0.02%) , DGX Quest Diagnostics $115.77 / -1.73 (-1.47%) , DXCM DexCom $405.52 / -1.49 (-0.37%) , EXAS Exact Sciences $135.04 / -3.84 (-2.76%) , HOLX Hologic $75.15 / -0.4 (-0.53%) , JNJ Johnson & Johnson $162.61 / +2.105 (+1.31%) , MDT Medtronic $118.73 / +0.71 (+0.60%) , MTD Mettler-Toledo $1,126.92 / +15.75 (+1.42%) , PEN Penumbra $288.57 / +8.5 (+3.03%) , PODD Insulet $262.39 / +1.9 (+0.73%) , SHC Sotera Health $26.72 / +0.28 (+1.06%) , SLQT SelectQuote $30.76 / +0.795 (+2.65%) , TECH Bio-Techne $374.73 / -2.58 (-0.68%) , TNDM TNDM / + , ZBH Zimmer Biomet $163.78 / +1.96 (+1.21%) 2021 Healthcare Services,… 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZBH TNDM TECH SLQT SHC PODD PEN MTD MDT JNJ HOLX EXAS DXCM DGX BIO ZBH Zimmer Biomet $163.78 / +1.96 (+1.21%) 02/22/21 Zimmer Biomet names Align Technology CDO to board 02/16/21 Zimmer Biomet says Vafa Jamali appointed as CEO of 'NewCo' 02/05/21 Zimmer Biomet announces intention to spin off spine, dental businesses 01/19/21 Zimmer Biomet appoints Ellison Humphrey as Chief Transformation Officer TNDM TNDM / + 11/23/20 Tandem Diabetes enters new agreements with DexCom 11/23/20 Tandem says Health Canada approves t:slim X2 Insulin pump TECH Bio-Techne $374.73 / -2.58 (-0.68%) 02/23/21 Bio-Techne, Luminary Therapeutics sign license agreement for us of TcBuster 02/08/21 Kantaro Biosciences signs marketing and distribution agreement with Atrys 01/28/21 Bio-Techne announces strategic investment in Eminence 12/02/20 Bio-Techne and Regulus collaborate in biomarker development SLQT SelectQuote $30.76 / +0.795 (+2.65%) 09/01/20 SelectQuote announces first partnership with primary care provider Iora Health SHC Sotera Health $26.72 / +0.28 (+1.06%) 12/18/20 Sotera Health announces debt pay down, expansion of revolving credit facility PODD Insulet $262.39 / +1.9 (+0.73%) 12/28/20 Insulet announces settlement of dispute with Ypsomed AG 09/21/20 Insulet launches Omnipod DASH System in additional countries PEN Penumbra $288.57 / +8.5 (+3.03%) 12/16/20 Penumbra falls -9.7% 12/16/20 Penumbra falls -10.6% 12/15/20 Penumbra recalls JET 7 Reperfusion Catheters with Xtra Flex technology 12/08/20 Penumbra down 12%, off earlier lows after issuing response to short seller MTD Mettler-Toledo $1,126.92 / +15.75 (+1.42%) 12/15/20 Mettler-Toledo CEO Olivier Filliol to step down, Patrick Kaltenbach to succeed 11/05/20 Mettler-Toledo announces additional $2.5B share repurchase program MDT Medtronic $118.73 / +0.71 (+0.60%) 02/23/21 Medtronic says new products driving share gains 02/18/21 Medtronic granted FDA approval for expanded labeling of InterStim MRI leads 02/17/21 Medtronic announces recall of unused Valiant Navion thoracic stent graft system 02/17/21 Medtronic announces recall of unused Valiant Navion thoracic stent graft system JNJ Johnson & Johnson $162.61 / +2.105 (+1.31%) 02/24/21 J&J's Janssen announces submission of sNDA to FDA for expanded Cabenuva use 02/24/21 FDA staff sees 'no specific safety concerns' to preclude EUA for J&J vaccine 02/24/21 J&J vaccine effective in preventing Covid-19, FDA panel says 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony HOLX Hologic $75.15 / -0.4 (-0.53%) 02/15/21 Fly Intel: Top five weekend stock stories 02/01/21 Hologic, Google Cloud collaborate over digital diagnostic capabilities 01/08/21 Hologic announces new, five-year $1B share repurchase plan 01/05/21 Hologic to acquire Biotheranostics for about $230M EXAS Exact Sciences $135.04 / -3.84 (-2.76%) 02/16/21 Exact Sciences to acquire Ashion Analytics, terms not disclosed 02/16/21 Exact Sciences to acquire Ashion Analytics, terms not disclosed 01/13/21 Exact Sciences reports worldwide exclusive license for TARDIS technology 01/12/21 Exact Sciences announces new data on Cologuard published in cancer journal DXCM DexCom $405.52 / -1.49 (-0.37%) 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/12/21 DexCom CEO: Everything about G7 will be better than G6 02/11/21 DexCom launches inaugural venture capital fund 01/14/21 DexCom CEO sells 47K shares of common stock DGX Quest Diagnostics $115.77 / -1.73 (-1.47%) 02/24/21 Quest Diagnostics launches COVID-19 semi-quantitative serology test service 02/23/21 Quest Diagnostics announces board leadership changes 02/23/21 GRAIL and Quest Diagnostics in pact to provide phlebotomy services for test 02/23/21 Quotient names Manuel Mendez as CEO, succeeding Franz Walt BIO Bio-Rad $594.44 / +0.09 (+0.02%) 10/29/20 Bio-Rad sees FY20 currency neutral sales up 5.9%-6.3% y/y BIO DGX DXCM EXAS HOLX JNJ MDT MTD PEN PODD SHC SLQT TECH TNDM ZBH BIO Bio-Rad $594.44 / +0.09 (+0.02%) 02/12/21 Citi Bio-Rad price target raised to $750 from $675 at Citi 02/05/21 Jefferies Bio-Rad price target raised to $725 from $660 at Jefferies 10/30/20 Citi Bio-Rad price target raised to $675 from $625 at Citi 10/30/20 Wells Fargo Bio-Rad price target raised to $650 from $590 at Wells Fargo DGX Quest Diagnostics $115.77 / -1.73 (-1.47%) 01/29/21 Citi Quest Diagnostics price target raised to $158 from $151 at Citi 12/17/20 Morgan Stanley Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown 12/17/20 Morgan Stanley Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley 10/26/20 Mizuho Quest Diagnostics price target raised to $149 from $144 at Mizuho DXCM DexCom $405.52 / -1.49 (-0.37%) 02/12/21 Oppenheimer DexCom price target raised to $449 from $415 at Oppenheimer 02/12/21 Citi DexCom price target lowered to $480 from $485 at Citi 02/12/21 Piper Sandler DexCom earnings selloff should be bought, says Piper Sandler 01/29/21 Piper Sandler DexCom price target raised to $500 from $465 at Piper Sandler EXAS Exact Sciences $135.04 / -3.84 (-2.76%) 02/18/21 Baird Exact Sciences price target lowered to $163 from $169 at Baird 02/17/21 Stifel Exact Sciences price target raised to $165 from $150 at Stifel 02/17/21 SVB Leerink Exact Sciences price target raised to $180 from $170 at SVB Leerink 02/17/21 Cowen Exact Sciences price target raised to $180 from $154 at Cowen HOLX Hologic $75.15 / -0.4 (-0.53%) 02/22/21 BTIG Hologic price target raised to $91 from $84 at BTIG 01/28/21 Wells Fargo Hologic price target raised to $95 from $90 at Wells Fargo 12/08/20 Argus Hologic price target raised to $100 from $85 at Argus 11/20/20 Fly Intel: Top five analyst downgrades JNJ Johnson & Johnson $162.61 / +2.105 (+1.31%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MDT Medtronic $118.73 / +0.71 (+0.60%) 02/24/21 Cowen Medtronic price target raised to $135 from $120 at Cowen 02/24/21 Stifel Medtronic price target raised to $135 after earnings at Stifel 02/23/21 Piper Sandler Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler MTD Mettler-Toledo $1,126.92 / +15.75 (+1.42%) 02/05/21 Wells Fargo Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo 01/04/21 Fly Intel: Top five analyst upgrades 01/04/21 Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history 01/04/21 Evercore ISI Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI PEN Penumbra $288.57 / +8.5 (+3.03%) 02/24/21 Canaccord Penumbra price target raised to $310 from $204 at Canaccord 02/24/21 Wells Fargo Penumbra price target raised to $310 from $260 at Wells Fargo 02/24/21 Citi Penumbra price target raised to $325 from $255 at Citi 12/16/20 Fly Intel: Top five analyst downgrades PODD Insulet $262.39 / +1.9 (+0.73%) 02/24/21 Raymond James Insulet price target raised to $296 from $282 at Raymond James 02/04/21 Piper Sandler Tandem trades at 'significant discount' to Insulet, says Piper Sandler 01/29/21 Piper Sandler Insulet downgraded to Neutral from Overweight at Piper Sandler 12/16/20 Citi Insulet downgraded to Neutral from Buy at Citi SHC Sotera Health $26.72 / +0.28 (+1.06%) 01/13/21 Baird Sotera Health initiated with an Outperform at Baird 12/15/20 KeyBanc Sotera Health initiated with an Overweight at KeyBanc 12/15/20 JPMorgan Sotera Health initiated with an Overweight at JPMorgan 12/15/20 Jefferies Sotera Health initiated with a Buy at Jefferies SLQT SelectQuote $30.76 / +0.795 (+2.65%) 02/10/21 Citi SelectQuote price target raised to $34 from $32 at Citi 02/09/21 Evercore ISI SelectQuote price target raised to $38 from $35 at Evercore ISI 02/09/21 Barclays SelectQuote price target raised to $36 from $32 at Barclays 10/06/20 Credit Suisse Walmart entry shows attractiveness of insurance market, says Credit Suisse TECH Bio-Techne $374.73 / -2.58 (-0.68%) 02/23/21 Stifel Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance 02/23/21 Stifel Bio-Techne upgraded to Buy from Hold at Stifel 02/03/21 Craig-Hallum Bio-Techne price target raised to $440 from $352 at Craig-Hallum 02/03/21 Citi Bio-Techne price target raised to $400 from $310 at Citi TNDM TNDM / + 01/21/21 Citi Citi adds Tandem, removes Guardant from 'Value Creators' list 12/15/20 Wells Fargo Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up 12/15/20 Wells Fargo Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo ZBH Zimmer Biomet $163.78 / +1.96 (+1.21%) 02/09/21 Piper Sandler Zimmer Biomet multiple should move higher into spin, says Piper Sandler 02/08/21 SVB Leerink Zimmer Biomet price target raised to $190 from $185 at SVB Leerink 02/08/21 Wells Fargo Zimmer Biomet price target raised to $176 from $165 at Wells Fargo 02/08/21 Deutsche Bank Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank ZBH TNDM TECH SLQT SHC PODD PEN MTD MDT JNJ HOLX EXAS DXCM DGX BIO ZBH Zimmer Biomet $163.78 / +1.96 (+1.21%) 02/05/21 Zimmer Biomet reports Q4 adjusted EPS 2.11, consensus $2.06 02/04/21 Notable companies reporting before tomorrow's open 11/06/20 Zimmer Biomet not providing Q4 guidance TNDM TNDM / + 11/05/20 Tandem Diabetes raises FY20 revenue view to $465M-$475M from $450M-$465M 11/05/20 Tandem Diabetes reports Q3 EPS (15c), consensus (10c) TECH Bio-Techne $374.73 / -2.58 (-0.68%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09 SLQT SelectQuote $30.76 / +0.795 (+2.65%) 02/08/21 SelectQuote raises FY21 revenue view to $920M-$940M from $840M-$880M 02/08/21 SelectQuote reports Q2 EPS 55c, consensus 44c 11/05/20 SelectQuote raises FY21 revenue view to $840M-$880M from $775M-$815M 11/05/20 SelectQuote reports Q1 EPS 1c, consensus (4c) SHC Sotera Health $26.72 / +0.28 (+1.06%) 01/11/21 Sotera Health reports preliminary 2020 revenue $817M, consensus $814.05M 01/11/21 Sotera Health reports preliminary Q4 revenue $216M, consensus $206.91M PODD Insulet $262.39 / +1.9 (+0.73%) 02/23/21 Insulet reports Q4 EPS (26c), consensus (4c) 11/04/20 Insulet raises FY20 revenue growth guidance to 20%-21% from 17%-19% 11/04/20 Insulet reports Q3 EPS 17c, consensus 8c PEN Penumbra $288.57 / +8.5 (+3.03%) 02/23/21 Penumbra sees FY21 revenue $675M-$685M, consensus $654.52M 02/23/21 Penumbra reports Q4 EPS 10c, consensus (7c) 01/11/21 Penumbra sees FY20 adjusted revenue $566M-$566.4M, consensus $531.88M 01/11/21 Penumbra sees Q4 adjusted revenue $172.5M-$172.9M, consensus $135.25M MTD Mettler-Toledo $1,126.92 / +15.75 (+1.42%) 02/04/21 Mettler-Toledo sees Q1 adjusted EPS $5.55-$5.70, consensus $5.14 02/04/21 Mettler-Toledo raises FY21 adjusted EPS view to $29.20-$29.80 from $27.50-$28.30 02/04/21 Mettler-Toledo reports Q4 adjusted EPS $9.26, consensus $8.72 11/05/20 Mettler-Toledo sees FY21 adjusted EPS $27.50-$28.30, consensus $26.28 MDT Medtronic $118.73 / +0.71 (+0.60%) 02/23/21 Medtronic reports Q3 EPS $1.29, consensus $1.15 11/24/20 Medtronic reports Q2 EPS $1.02, consensus 80c 10/14/20 Medtronic sees long-term annual organic revenue growth of 5% 08/25/20 Medtronic not providing guidance at this time JNJ Johnson & Johnson $162.61 / +2.105 (+1.31%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open HOLX Hologic $75.15 / -0.4 (-0.53%) 01/27/21 Hologic sees Q2 adjusted EPS $2.56-$2.68, consensus $2.02 01/27/21 Hologic reports Q1 adjusted EPS $2.86, consensus $2.17 01/27/21 Notable companies reporting after market close 01/08/21 Hologic reports preliminary Q1 revenue $1.61B, consensus $1.38B EXAS Exact Sciences $135.04 / -3.84 (-2.76%) 02/16/21 Exact Sciences reports Q4 EPS ($2.79), consensus (22c) 02/16/21 Notable companies reporting after market close 01/10/21 Exact Sciences reports preliminary Q4 revenue $464.5M-$467.5M, consensus $431.2M 10/27/20 Exact Sciences reports Q3 EPS ($1.46), consensus (52c) DXCM DexCom $405.52 / -1.49 (-0.37%) 02/11/21 DexCom sees FY21 revenue $2.21B-$2.31B, consensus $2.33B 02/11/21 DexCom reports Q4 EPS $3.48, consensus 92c 01/11/21 DexCom sees FY20 revenue $1.93B, consensus $1.91B 01/11/21 DexCom reports preliminary Q4 revenue at least $567M, consensus $550.73M DGX Quest Diagnostics $115.77 / -1.73 (-1.47%) 02/04/21 Quest Diagnostics sees first half adjusted EPS $5.90-$6.90 02/04/21 Quest Diagnostics reports Q4 adjusted EPS $4.48, consensus $4.24 02/03/21 Notable companies reporting before tomorrow's open BIO Bio-Rad $594.44 / +0.09 (+0.02%) 02/11/21 Bio-Rad sees FY21 revenue growth of 4.5%-5.0% 02/11/21 Bio-Rad reports Q4 EPS $4.01, consensus $3.29 12/10/20 Bio-Rad sees FY23 revenue $2.75B-$2.85B 10/29/20 Bio-Rad reports Q3 adjusted EPS $3.00, consensus $1.80 20 Nov 28 May 21 May 13 May PEN MDT JNJ HOLX PEN Penumbra $288.57 / +8.5 (+3.03%) 12/28/20 Penumbra named a short at Marcus Aurelius, says company 'cannot be trusted' 12/08/20 Penumbra tells CNBC short seller claims are 'baseless' 11/10/20 Quintessential Capital issues short report on Penumbra with $55 target 11/10/20 Penumbra named short idea by Quintessential Capital MDT Medtronic $118.73 / +0.71 (+0.60%) 10/01/20 DOJ opens ventilator antitrust probe with Medtronic focus, WSJ reports 09/30/20 DoJ opens ventilator antitrust probe with Medtronic focus, WSJ says JNJ Johnson & Johnson $162.61 / +2.105 (+1.31%) 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports 02/16/21 South Africa to share AstraZeneca COVID-19 vaccine doses, Reuters reports 02/09/21 J&J CEO says Covid vaccine may be given annually, like the flu, CNBC reports 02/02/21 Johnson & Johnson seeks approval of COVID-19 vaccine in Thailand, Reuters says HOLX Hologic $75.15 / -0.4 (-0.53%) 02/13/21 Hologic looks cheap, time to buy, Barron's says ZBH SLQT SHC PEN MTD MDT JNJ HOLX EXAS DXCM DGX ZBH Zimmer Biomet $163.78 / +1.96 (+1.21%) 02/05/21 Fly Intel: Pre-market Movers SLQT SelectQuote $30.76 / +0.795 (+2.65%) 02/08/21 Fly Intel: After-Hours Movers 11/16/20 Fly Intel: What to watch in Walmart's earnings report 09/10/20 Fly Intel: Pre-market Movers 09/09/20 Fly Intel: After-Hours Movers SHC Sotera Health $26.72 / +0.28 (+1.06%) 11/22/20 Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO PEN Penumbra $288.57 / +8.5 (+3.03%) 02/23/21 Fly Intel: After-Hours Movers 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/16/20 Short-seller target Penumbra slides after recall of JET 7 catheters MTD Mettler-Toledo $1,126.92 / +15.75 (+1.42%) 02/04/21 Fly Intel: After-Hours Movers MDT Medtronic $118.73 / +0.71 (+0.60%) 10/08/20 Tesla upgrade, Citi downgrade among today's top calls on Wall Street 08/25/20 Fly Intel: Wall Street's top stories for Tuesday 08/25/20 Fly Intel: Wall Street's top stories at midday 08/25/20 Fly Intel: Pre-market Movers JNJ Johnson & Johnson $162.61 / +2.105 (+1.31%) 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday HOLX Hologic $75.15 / -0.4 (-0.53%) 01/27/21 Fly Intel: After-Hours Movers 11/20/20 Nikola initiation at Loop among today's top calls on Wall Street 08/27/20 Fly Intel: Wall Street's top stories at midday 08/27/20 Abbott Labs jumps after securing FDA approval for $5 COVID-19 test EXAS Exact Sciences $135.04 / -3.84 (-2.76%) 02/16/21 Fly Intel: After-Hours Movers 10/28/20 AMD, Lululemon upgrades among today's top calls on Wall Street 10/27/20 Fly Intel: Wall Street's top stories for Tuesday 10/27/20 Fly Intel: Wall Street's top stories at midday DXCM DexCom $405.52 / -1.49 (-0.37%) 02/11/21 Fly Intel: After-Hours Movers 01/11/21 Fly Intel: Pre-market Movers 10/26/20 Fly Intel: After-Hours Movers 10/02/20 DexCom downgrade, Shake Shack initiation among today's top calls on Wall Street DGX Quest Diagnostics $115.77 / -1.73 (-1.47%) 02/04/21 Fly Intel: Pre-market Movers 12/17/20 AT&T downgrade, Yum! Brands upgrade among today's top calls on Wall Street 12/16/20 Fly Intel: Pre-market Movers 10/26/20 Fly Insider: Selecta, Netflix among week's notable insider trades 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 02/25/21 10th Annual Global Healthcare Virtual Conference 02/25/21 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference 03/01/21 42nd Annual Institutional Investors Virtual Conference 00:00 Today 41st Annual Healthcare Virtual Conference 04/20/21 Johnson & Johnson - JNJ 03/08/21 Tandem Diabetes 03/11/21 Hologic Inc 03/11/21 Quest Diagnostics Incorporated 05/21/21 Quest Diagnostics Incorporated ZBH SLQT MDT JNJ HOLX EXAS DGX BIO ZBH Zimmer Biomet $163.78 / +1.96 (+1.21%) 12/29/20 Early notable gainers among liquid option names on December 29th SLQT SelectQuote $30.76 / +0.795 (+2.65%) 02/08/21 SelectQuote options imply 13.0% move in share price post-earnings 01/19/21 Unusual call flow in option market yesterday 01/15/21 SelectQuote call buyer as shares jump MDT Medtronic $118.73 / +0.71 (+0.60%) 02/23/21 Early notable gainers among liquid option names on February 23rd 10/08/20 Unusually active option classes on open October 8th 08/25/20 Early notable gainers among liquid option names on August 25th 08/25/20 Unusually active option classes on open August 25th JNJ Johnson & Johnson $162.61 / +2.105 (+1.31%) 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd HOLX Hologic $75.15 / -0.4 (-0.53%) 02/01/21 Early notable gainers among liquid option names on February 1st 01/08/21 Early notable gainers among liquid option names on January 8th 10/26/20 Early notable gainers among liquid option names on October 26th 09/11/20 Early notable gainers among liquid option names on September 11th EXAS Exact Sciences $135.04 / -3.84 (-2.76%) 10/23/20 EXACT Sciences call volume above normal and directionally bullish DGX Quest Diagnostics $115.77 / -1.73 (-1.47%) 10/23/20 Early notable gainers among liquid option names on October 23rd 10/16/20 Early notable gainers among liquid option names on October 16th BIO Bio-Rad $594.44 / +0.09 (+0.02%) 02/12/21 Early notable gainers among liquid option names on February 12th

Wednesday
Conference/Events	Citigroup to hold a virtual conference » 04:55 02/24/21 02/24 04:55 02/24/21 04:55 BIO Bio-Rad $594.35 / -8.99 (-1.49%) , DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) , DXCM DexCom $406.68 / -5.06 (-1.23%) , EXAS Exact Sciences $138.96 / -3.4 (-2.39%) , HOLX Hologic $75.56 / +0.96 (+1.29%) , JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) , MDT Medtronic $118.01 / +2.26 (+1.95%) , MTD Mettler-Toledo $1,110.50 / -24.39 (-2.15%) , PEN Penumbra $280.77 / +0.9 (+0.32%) , PODD Insulet $261.12 / +4.25 (+1.65%) , SHC Sotera Health $26.39 / -0.86 (-3.16%) , SLQT SelectQuote $29.96 / -0.09 (-0.30%) , TECH Bio-Techne $376.78 / +0.05 (+0.01%) , TNDM TNDM / + , ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 2021 Healthcare Services,… 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZBH TNDM TECH SLQT SHC PODD PEN MTD MDT JNJ HOLX EXAS DXCM DGX BIO ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 02/22/21 Zimmer Biomet names Align Technology CDO to board 02/16/21 Zimmer Biomet says Vafa Jamali appointed as CEO of 'NewCo' 02/05/21 Zimmer Biomet announces intention to spin off spine, dental businesses 01/19/21 Zimmer Biomet appoints Ellison Humphrey as Chief Transformation Officer TNDM TNDM / + 11/23/20 Tandem Diabetes enters new agreements with DexCom 11/23/20 Tandem says Health Canada approves t:slim X2 Insulin pump TECH Bio-Techne $376.78 / +0.05 (+0.01%) 02/23/21 Bio-Techne, Luminary Therapeutics sign license agreement for us of TcBuster 02/08/21 Kantaro Biosciences signs marketing and distribution agreement with Atrys 01/28/21 Bio-Techne announces strategic investment in Eminence 12/02/20 Bio-Techne and Regulus collaborate in biomarker development SLQT SelectQuote $29.96 / -0.09 (-0.30%) 09/01/20 SelectQuote announces first partnership with primary care provider Iora Health SHC Sotera Health $26.39 / -0.86 (-3.16%) 12/18/20 Sotera Health announces debt pay down, expansion of revolving credit facility PODD Insulet $261.12 / +4.25 (+1.65%) 12/28/20 Insulet announces settlement of dispute with Ypsomed AG 09/21/20 Insulet launches Omnipod DASH System in additional countries PEN Penumbra $280.77 / +0.9 (+0.32%) 12/16/20 Penumbra falls -9.7% 12/16/20 Penumbra falls -10.6% 12/15/20 Penumbra recalls JET 7 Reperfusion Catheters with Xtra Flex technology 12/08/20 Penumbra down 12%, off earlier lows after issuing response to short seller MTD Mettler-Toledo $1,110.50 / -24.39 (-2.15%) 12/15/20 Mettler-Toledo CEO Olivier Filliol to step down, Patrick Kaltenbach to succeed 11/05/20 Mettler-Toledo announces additional $2.5B share repurchase program MDT Medtronic $118.01 / +2.26 (+1.95%) 02/23/21 Medtronic says new products driving share gains 02/18/21 Medtronic granted FDA approval for expanded labeling of InterStim MRI leads 02/17/21 Medtronic announces recall of unused Valiant Navion thoracic stent graft system 02/17/21 Medtronic announces recall of unused Valiant Navion thoracic stent graft system JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/19/21 Janssen submits for EUL to WHO for single-shot COVID vaccine candidate 02/10/21 Model N discloses J&J agreed to transition to its Revenue Cloud for Life Science 02/08/21 J&J's Janssen says ACIS study meets primary endpoint of rPFS HOLX Hologic $75.56 / +0.96 (+1.29%) 02/15/21 Fly Intel: Top five weekend stock stories 02/01/21 Hologic, Google Cloud collaborate over digital diagnostic capabilities 01/08/21 Hologic announces new, five-year $1B share repurchase plan 01/05/21 Hologic to acquire Biotheranostics for about $230M EXAS Exact Sciences $138.96 / -3.4 (-2.39%) 02/16/21 Exact Sciences to acquire Ashion Analytics, terms not disclosed 02/16/21 Exact Sciences to acquire Ashion Analytics, terms not disclosed 01/13/21 Exact Sciences reports worldwide exclusive license for TARDIS technology 01/12/21 Exact Sciences announces new data on Cologuard published in cancer journal DXCM DexCom $406.68 / -5.06 (-1.23%) 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/12/21 DexCom CEO: Everything about G7 will be better than G6 02/11/21 DexCom launches inaugural venture capital fund 01/14/21 DexCom CEO sells 47K shares of common stock DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) 02/23/21 Quest Diagnostics announces board leadership changes 02/23/21 GRAIL and Quest Diagnostics in pact to provide phlebotomy services for test 02/23/21 Quotient names Manuel Mendez as CEO, succeeding Franz Walt 02/16/21 Quest Diagnostics, EmblemHealth renew strategic relationship BIO Bio-Rad $594.35 / -8.99 (-1.49%) 10/29/20 Bio-Rad sees FY20 currency neutral sales up 5.9%-6.3% y/y BIO DGX DXCM EXAS HOLX JNJ MDT MTD PEN PODD SHC SLQT TECH TNDM ZBH BIO Bio-Rad $594.35 / -8.99 (-1.49%) 02/12/21 Citi Bio-Rad price target raised to $750 from $675 at Citi 02/05/21 Jefferies Bio-Rad price target raised to $725 from $660 at Jefferies 10/30/20 Citi Bio-Rad price target raised to $675 from $625 at Citi 10/30/20 Wells Fargo Bio-Rad price target raised to $650 from $590 at Wells Fargo DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) 01/29/21 Citi Quest Diagnostics price target raised to $158 from $151 at Citi 12/17/20 Morgan Stanley Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown 12/17/20 Morgan Stanley Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley 10/26/20 Mizuho Quest Diagnostics price target raised to $149 from $144 at Mizuho DXCM DexCom $406.68 / -5.06 (-1.23%) 02/12/21 Oppenheimer DexCom price target raised to $449 from $415 at Oppenheimer 02/12/21 Citi DexCom price target lowered to $480 from $485 at Citi 02/12/21 Piper Sandler DexCom earnings selloff should be bought, says Piper Sandler 01/29/21 Piper Sandler DexCom price target raised to $500 from $465 at Piper Sandler EXAS Exact Sciences $138.96 / -3.4 (-2.39%) 02/18/21 Baird Exact Sciences price target lowered to $163 from $169 at Baird 02/17/21 Stifel Exact Sciences price target raised to $165 from $150 at Stifel 02/17/21 SVB Leerink Exact Sciences price target raised to $180 from $170 at SVB Leerink 02/17/21 Cowen Exact Sciences price target raised to $180 from $154 at Cowen HOLX Hologic $75.56 / +0.96 (+1.29%) 02/22/21 BTIG Hologic price target raised to $91 from $84 at BTIG 01/28/21 Wells Fargo Hologic price target raised to $95 from $90 at Wells Fargo 12/08/20 Argus Hologic price target raised to $100 from $85 at Argus 11/20/20 Fly Intel: Top five analyst downgrades JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MDT Medtronic $118.01 / +2.26 (+1.95%) 02/23/21 Piper Sandler Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler 01/11/21 Piper Sandler Medtronic updates thoughts on Q3, products, says Piper Sandler 01/07/21 Morgan Stanley Axonics price target raised to $58 from $53 at Morgan Stanley MTD Mettler-Toledo $1,110.50 / -24.39 (-2.15%) 02/05/21 Wells Fargo Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo 01/04/21 Fly Intel: Top five analyst upgrades 01/04/21 Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history 01/04/21 Evercore ISI Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI PEN Penumbra $280.77 / +0.9 (+0.32%) 12/16/20 Fly Intel: Top five analyst downgrades 12/16/20 Wells Fargo Penumbra price target lowered to $215 from $265 at Wells Fargo 12/16/20 Canaccord Penumbra price target lowered to $204 from $292 at Canaccord 12/16/20 Citi Citi keeps Buy rating on Penumbra, says recall 'clearning event' PODD Insulet $261.12 / +4.25 (+1.65%) 02/04/21 Piper Sandler Tandem trades at 'significant discount' to Insulet, says Piper Sandler 01/29/21 Piper Sandler Insulet downgraded to Neutral from Overweight at Piper Sandler 12/16/20 Citi Insulet downgraded to Neutral from Buy at Citi 11/05/20 Wells Fargo Insulet price target raised to $266 from $250 at Wells Fargo SHC Sotera Health $26.39 / -0.86 (-3.16%) 01/13/21 Baird Sotera Health initiated with an Outperform at Baird 12/15/20 KeyBanc Sotera Health initiated with an Overweight at KeyBanc 12/15/20 JPMorgan Sotera Health initiated with an Overweight at JPMorgan 12/15/20 Jefferies Sotera Health initiated with a Buy at Jefferies SLQT SelectQuote $29.96 / -0.09 (-0.30%) 02/10/21 Citi SelectQuote price target raised to $34 from $32 at Citi 02/09/21 Evercore ISI SelectQuote price target raised to $38 from $35 at Evercore ISI 02/09/21 Barclays SelectQuote price target raised to $36 from $32 at Barclays 10/06/20 Credit Suisse Walmart entry shows attractiveness of insurance market, says Credit Suisse TECH Bio-Techne $376.78 / +0.05 (+0.01%) 02/23/21 Stifel Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance 02/23/21 Stifel Bio-Techne upgraded to Buy from Hold at Stifel 02/03/21 Craig-Hallum Bio-Techne price target raised to $440 from $352 at Craig-Hallum 02/03/21 Citi Bio-Techne price target raised to $400 from $310 at Citi TNDM TNDM / + 01/21/21 Citi Citi adds Tandem, removes Guardant from 'Value Creators' list 12/15/20 Wells Fargo Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up 12/15/20 Wells Fargo Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 02/09/21 Piper Sandler Zimmer Biomet multiple should move higher into spin, says Piper Sandler 02/08/21 SVB Leerink Zimmer Biomet price target raised to $190 from $185 at SVB Leerink 02/08/21 Wells Fargo Zimmer Biomet price target raised to $176 from $165 at Wells Fargo 02/08/21 Deutsche Bank Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank ZBH TNDM TECH SLQT SHC PODD PEN MTD MDT JNJ HOLX EXAS DXCM DGX BIO ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 02/05/21 Zimmer Biomet reports Q4 adjusted EPS 2.11, consensus $2.06 02/04/21 Notable companies reporting before tomorrow's open 11/06/20 Zimmer Biomet not providing Q4 guidance TNDM TNDM / + 11/05/20 Tandem Diabetes raises FY20 revenue view to $465M-$475M from $450M-$465M 11/05/20 Tandem Diabetes reports Q3 EPS (15c), consensus (10c) TECH Bio-Techne $376.78 / +0.05 (+0.01%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09 SLQT SelectQuote $29.96 / -0.09 (-0.30%) 02/08/21 SelectQuote raises FY21 revenue view to $920M-$940M from $840M-$880M 02/08/21 SelectQuote reports Q2 EPS 55c, consensus 44c 11/05/20 SelectQuote raises FY21 revenue view to $840M-$880M from $775M-$815M 11/05/20 SelectQuote reports Q1 EPS 1c, consensus (4c) SHC Sotera Health $26.39 / -0.86 (-3.16%) 01/11/21 Sotera Health reports preliminary 2020 revenue $817M, consensus $814.05M 01/11/21 Sotera Health reports preliminary Q4 revenue $216M, consensus $206.91M PODD Insulet $261.12 / +4.25 (+1.65%) 02/23/21 Insulet reports Q4 EPS (26c), consensus (4c) 11/04/20 Insulet raises FY20 revenue growth guidance to 20%-21% from 17%-19% 11/04/20 Insulet reports Q3 EPS 17c, consensus 8c PEN Penumbra $280.77 / +0.9 (+0.32%) 02/23/21 Penumbra sees FY21 revenue $675M-$685M, consensus $654.52M 02/23/21 Penumbra reports Q4 EPS 10c, consensus (7c) 01/11/21 Penumbra sees FY20 adjusted revenue $566M-$566.4M, consensus $531.88M 01/11/21 Penumbra sees Q4 adjusted revenue $172.5M-$172.9M, consensus $135.25M MTD Mettler-Toledo $1,110.50 / -24.39 (-2.15%) 02/04/21 Mettler-Toledo sees Q1 adjusted EPS $5.55-$5.70, consensus $5.14 02/04/21 Mettler-Toledo raises FY21 adjusted EPS view to $29.20-$29.80 from $27.50-$28.30 02/04/21 Mettler-Toledo reports Q4 adjusted EPS $9.26, consensus $8.72 11/05/20 Mettler-Toledo sees FY21 adjusted EPS $27.50-$28.30, consensus $26.28 MDT Medtronic $118.01 / +2.26 (+1.95%) 02/23/21 Medtronic reports Q3 EPS $1.29, consensus $1.15 11/24/20 Medtronic reports Q2 EPS $1.02, consensus 80c 10/14/20 Medtronic sees long-term annual organic revenue growth of 5% 08/25/20 Medtronic not providing guidance at this time JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open HOLX Hologic $75.56 / +0.96 (+1.29%) 01/27/21 Hologic sees Q2 adjusted EPS $2.56-$2.68, consensus $2.02 01/27/21 Hologic reports Q1 adjusted EPS $2.86, consensus $2.17 01/27/21 Notable companies reporting after market close 01/08/21 Hologic reports preliminary Q1 revenue $1.61B, consensus $1.38B EXAS Exact Sciences $138.96 / -3.4 (-2.39%) 02/16/21 Exact Sciences reports Q4 EPS ($2.79), consensus (22c) 02/16/21 Notable companies reporting after market close 01/10/21 Exact Sciences reports preliminary Q4 revenue $464.5M-$467.5M, consensus $431.2M 10/27/20 Exact Sciences reports Q3 EPS ($1.46), consensus (52c) DXCM DexCom $406.68 / -5.06 (-1.23%) 02/11/21 DexCom sees FY21 revenue $2.21B-$2.31B, consensus $2.33B 02/11/21 DexCom reports Q4 EPS $3.48, consensus 92c 01/11/21 DexCom sees FY20 revenue $1.93B, consensus $1.91B 01/11/21 DexCom reports preliminary Q4 revenue at least $567M, consensus $550.73M DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) 02/04/21 Quest Diagnostics sees first half adjusted EPS $5.90-$6.90 02/04/21 Quest Diagnostics reports Q4 adjusted EPS $4.48, consensus $4.24 02/03/21 Notable companies reporting before tomorrow's open BIO Bio-Rad $594.35 / -8.99 (-1.49%) 02/11/21 Bio-Rad sees FY21 revenue growth of 4.5%-5.0% 02/11/21 Bio-Rad reports Q4 EPS $4.01, consensus $3.29 12/10/20 Bio-Rad sees FY23 revenue $2.75B-$2.85B 10/29/20 Bio-Rad reports Q3 adjusted EPS $3.00, consensus $1.80 20 Nov 28 May 21 May 13 May PEN MDT JNJ HOLX PEN Penumbra $280.77 / +0.9 (+0.32%) 12/28/20 Penumbra named a short at Marcus Aurelius, says company 'cannot be trusted' 12/08/20 Penumbra tells CNBC short seller claims are 'baseless' 11/10/20 Quintessential Capital issues short report on Penumbra with $55 target 11/10/20 Penumbra named short idea by Quintessential Capital MDT Medtronic $118.01 / +2.26 (+1.95%) 10/01/20 DOJ opens ventilator antitrust probe with Medtronic focus, WSJ reports 09/30/20 DoJ opens ventilator antitrust probe with Medtronic focus, WSJ says JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 02/16/21 South Africa to share AstraZeneca COVID-19 vaccine doses, Reuters reports 02/09/21 J&J CEO says Covid vaccine may be given annually, like the flu, CNBC reports 02/02/21 Johnson & Johnson seeks approval of COVID-19 vaccine in Thailand, Reuters says 01/22/21 J&J director says company could boost vaccine availability by spring, CNBC says HOLX Hologic $75.56 / +0.96 (+1.29%) 02/13/21 Hologic looks cheap, time to buy, Barron's says ZBH SLQT SHC PEN MTD MDT JNJ HOLX EXAS DXCM DGX ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 02/05/21 Fly Intel: Pre-market Movers SLQT SelectQuote $29.96 / -0.09 (-0.30%) 02/08/21 Fly Intel: After-Hours Movers 11/16/20 Fly Intel: What to watch in Walmart's earnings report 09/10/20 Fly Intel: Pre-market Movers 09/09/20 Fly Intel: After-Hours Movers SHC Sotera Health $26.39 / -0.86 (-3.16%) 11/22/20 Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO PEN Penumbra $280.77 / +0.9 (+0.32%) 02/23/21 Fly Intel: After-Hours Movers 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/16/20 Short-seller target Penumbra slides after recall of JET 7 catheters MTD Mettler-Toledo $1,110.50 / -24.39 (-2.15%) 02/04/21 Fly Intel: After-Hours Movers MDT Medtronic $118.01 / +2.26 (+1.95%) 10/08/20 Tesla upgrade, Citi downgrade among today's top calls on Wall Street 08/25/20 Fly Intel: Wall Street's top stories for Tuesday 08/25/20 Fly Intel: Wall Street's top stories at midday 08/25/20 Fly Intel: Pre-market Movers JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 01/29/21 Fly Intel: Wall Street's top stories at midday HOLX Hologic $75.56 / +0.96 (+1.29%) 01/27/21 Fly Intel: After-Hours Movers 11/20/20 Nikola initiation at Loop among today's top calls on Wall Street 08/27/20 Fly Intel: Wall Street's top stories at midday 08/27/20 Abbott Labs jumps after securing FDA approval for $5 COVID-19 test EXAS Exact Sciences $138.96 / -3.4 (-2.39%) 02/16/21 Fly Intel: After-Hours Movers 10/28/20 AMD, Lululemon upgrades among today's top calls on Wall Street 10/27/20 Fly Intel: Wall Street's top stories for Tuesday 10/27/20 Fly Intel: Wall Street's top stories at midday DXCM DexCom $406.68 / -5.06 (-1.23%) 02/11/21 Fly Intel: After-Hours Movers 01/11/21 Fly Intel: Pre-market Movers 10/26/20 Fly Intel: After-Hours Movers 10/02/20 DexCom downgrade, Shake Shack initiation among today's top calls on Wall Street DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) 02/04/21 Fly Intel: Pre-market Movers 12/17/20 AT&T downgrade, Yum! Brands upgrade among today's top calls on Wall Street 12/16/20 Fly Intel: Pre-market Movers 10/26/20 Fly Insider: Selecta, Netflix among week's notable insider trades 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 02/25/21 10th Annual Global Healthcare Virtual Conference 02/25/21 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference 03/01/21 42nd Annual Institutional Investors Virtual Conference 00:00 Today 41st Annual Healthcare Virtual Conference 02/24/21 Tandem Diabetes - TNDM 04/20/21 Johnson & Johnson - JNJ 03/08/21 Tandem Diabetes 03/11/21 Hologic Inc 03/11/21 Quest Diagnostics Incorporated ZBH SLQT MDT JNJ HOLX EXAS DGX BIO ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 12/29/20 Early notable gainers among liquid option names on December 29th SLQT SelectQuote $29.96 / -0.09 (-0.30%) 02/08/21 SelectQuote options imply 13.0% move in share price post-earnings 01/19/21 Unusual call flow in option market yesterday 01/15/21 SelectQuote call buyer as shares jump MDT Medtronic $118.01 / +2.26 (+1.95%) 02/23/21 Early notable gainers among liquid option names on February 23rd 10/08/20 Unusually active option classes on open October 8th 08/25/20 Early notable gainers among liquid option names on August 25th 08/25/20 Unusually active option classes on open August 25th JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd HOLX Hologic $75.56 / +0.96 (+1.29%) 02/01/21 Early notable gainers among liquid option names on February 1st 01/08/21 Early notable gainers among liquid option names on January 8th 10/26/20 Early notable gainers among liquid option names on October 26th 09/11/20 Early notable gainers among liquid option names on September 11th EXAS Exact Sciences $138.96 / -3.4 (-2.39%) 10/23/20 EXACT Sciences call volume above normal and directionally bullish DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) 10/23/20 Early notable gainers among liquid option names on October 23rd 10/16/20 Early notable gainers among liquid option names on October 16th BIO Bio-Rad $594.35 / -8.99 (-1.49%) 02/12/21 Early notable gainers among liquid option names on February 12th

Over a week ago
Conference/Events	Citigroup to hold a virtual conference » 17:49 02/23/21 02/23 17:49 02/23/21 17:49 BIO Bio-Rad $594.35 / -8.99 (-1.49%) , DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) , DXCM DexCom $406.68 / -5.06 (-1.23%) , EXAS Exact Sciences $138.96 / -3.4 (-2.39%) , HOLX Hologic $75.56 / +0.96 (+1.29%) , JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) , MDT Medtronic $118.01 / +2.26 (+1.95%) , MTD Mettler-Toledo $1,110.50 / -24.39 (-2.15%) , PEN Penumbra $280.77 / +0.9 (+0.32%) , PODD Insulet $261.12 / +4.25 (+1.65%) , SHC Sotera Health $26.39 / -0.86 (-3.16%) , SLQT SelectQuote $29.96 / -0.09 (-0.30%) , TECH Bio-Techne $376.78 / +0.05 (+0.01%) , TNDM TNDM / + , ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 2021 Healthcare Services,… 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZBH TNDM TECH SLQT SHC PODD PEN MTD MDT JNJ HOLX EXAS DXCM DGX BIO ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 02/22/21 Zimmer Biomet names Align Technology CDO to board 02/16/21 Zimmer Biomet says Vafa Jamali appointed as CEO of 'NewCo' 02/05/21 Zimmer Biomet announces intention to spin off spine, dental businesses 01/19/21 Zimmer Biomet appoints Ellison Humphrey as Chief Transformation Officer TNDM TNDM / + 11/23/20 Tandem Diabetes enters new agreements with DexCom 11/23/20 Tandem says Health Canada approves t:slim X2 Insulin pump TECH Bio-Techne $376.78 / +0.05 (+0.01%) 02/23/21 Bio-Techne, Luminary Therapeutics sign license agreement for us of TcBuster 02/08/21 Kantaro Biosciences signs marketing and distribution agreement with Atrys 01/28/21 Bio-Techne announces strategic investment in Eminence 12/02/20 Bio-Techne and Regulus collaborate in biomarker development SLQT SelectQuote $29.96 / -0.09 (-0.30%) 09/01/20 SelectQuote announces first partnership with primary care provider Iora Health SHC Sotera Health $26.39 / -0.86 (-3.16%) 12/18/20 Sotera Health announces debt pay down, expansion of revolving credit facility PODD Insulet $261.12 / +4.25 (+1.65%) 12/28/20 Insulet announces settlement of dispute with Ypsomed AG 09/21/20 Insulet launches Omnipod DASH System in additional countries PEN Penumbra $280.77 / +0.9 (+0.32%) 12/16/20 Penumbra falls -9.7% 12/16/20 Penumbra falls -10.6% 12/15/20 Penumbra recalls JET 7 Reperfusion Catheters with Xtra Flex technology 12/08/20 Penumbra down 12%, off earlier lows after issuing response to short seller MTD Mettler-Toledo $1,110.50 / -24.39 (-2.15%) 12/15/20 Mettler-Toledo CEO Olivier Filliol to step down, Patrick Kaltenbach to succeed 11/05/20 Mettler-Toledo announces additional $2.5B share repurchase program MDT Medtronic $118.01 / +2.26 (+1.95%) 02/23/21 Medtronic says new products driving share gains 02/18/21 Medtronic granted FDA approval for expanded labeling of InterStim MRI leads 02/17/21 Medtronic announces recall of unused Valiant Navion thoracic stent graft system 02/17/21 Medtronic announces recall of unused Valiant Navion thoracic stent graft system JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/19/21 Janssen submits for EUL to WHO for single-shot COVID vaccine candidate 02/10/21 Model N discloses J&J agreed to transition to its Revenue Cloud for Life Science 02/08/21 J&J's Janssen says ACIS study meets primary endpoint of rPFS HOLX Hologic $75.56 / +0.96 (+1.29%) 02/15/21 Fly Intel: Top five weekend stock stories 02/01/21 Hologic, Google Cloud collaborate over digital diagnostic capabilities 01/08/21 Hologic announces new, five-year $1B share repurchase plan 01/05/21 Hologic to acquire Biotheranostics for about $230M EXAS Exact Sciences $138.96 / -3.4 (-2.39%) 02/16/21 Exact Sciences to acquire Ashion Analytics, terms not disclosed 02/16/21 Exact Sciences to acquire Ashion Analytics, terms not disclosed 01/13/21 Exact Sciences reports worldwide exclusive license for TARDIS technology 01/12/21 Exact Sciences announces new data on Cologuard published in cancer journal DXCM DexCom $406.68 / -5.06 (-1.23%) 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/12/21 DexCom CEO: Everything about G7 will be better than G6 02/11/21 DexCom launches inaugural venture capital fund 01/14/21 DexCom CEO sells 47K shares of common stock DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) 02/23/21 Quest Diagnostics announces board leadership changes 02/23/21 GRAIL and Quest Diagnostics in pact to provide phlebotomy services for test 02/23/21 Quotient names Manuel Mendez as CEO, succeeding Franz Walt 02/16/21 Quest Diagnostics, EmblemHealth renew strategic relationship BIO Bio-Rad $594.35 / -8.99 (-1.49%) 10/29/20 Bio-Rad sees FY20 currency neutral sales up 5.9%-6.3% y/y BIO DGX DXCM EXAS HOLX JNJ MDT MTD PEN PODD SHC SLQT TECH TNDM ZBH BIO Bio-Rad $594.35 / -8.99 (-1.49%) 02/12/21 Citi Bio-Rad price target raised to $750 from $675 at Citi 02/05/21 Jefferies Bio-Rad price target raised to $725 from $660 at Jefferies 10/30/20 Citi Bio-Rad price target raised to $675 from $625 at Citi 10/30/20 Wells Fargo Bio-Rad price target raised to $650 from $590 at Wells Fargo DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) 01/29/21 Citi Quest Diagnostics price target raised to $158 from $151 at Citi 12/17/20 Morgan Stanley Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown 12/17/20 Morgan Stanley Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley 10/26/20 Mizuho Quest Diagnostics price target raised to $149 from $144 at Mizuho DXCM DexCom $406.68 / -5.06 (-1.23%) 02/12/21 Oppenheimer DexCom price target raised to $449 from $415 at Oppenheimer 02/12/21 Citi DexCom price target lowered to $480 from $485 at Citi 02/12/21 Piper Sandler DexCom earnings selloff should be bought, says Piper Sandler 01/29/21 Piper Sandler DexCom price target raised to $500 from $465 at Piper Sandler EXAS Exact Sciences $138.96 / -3.4 (-2.39%) 02/18/21 Baird Exact Sciences price target lowered to $163 from $169 at Baird 02/17/21 Stifel Exact Sciences price target raised to $165 from $150 at Stifel 02/17/21 SVB Leerink Exact Sciences price target raised to $180 from $170 at SVB Leerink 02/17/21 Cowen Exact Sciences price target raised to $180 from $154 at Cowen HOLX Hologic $75.56 / +0.96 (+1.29%) 02/22/21 BTIG Hologic price target raised to $91 from $84 at BTIG 01/28/21 Wells Fargo Hologic price target raised to $95 from $90 at Wells Fargo 12/08/20 Argus Hologic price target raised to $100 from $85 at Argus 11/20/20 Fly Intel: Top five analyst downgrades JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MDT Medtronic $118.01 / +2.26 (+1.95%) 02/23/21 Piper Sandler Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler 01/11/21 Piper Sandler Medtronic updates thoughts on Q3, products, says Piper Sandler 01/07/21 Morgan Stanley Axonics price target raised to $58 from $53 at Morgan Stanley MTD Mettler-Toledo $1,110.50 / -24.39 (-2.15%) 02/05/21 Wells Fargo Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo 01/04/21 Fly Intel: Top five analyst upgrades 01/04/21 Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history 01/04/21 Evercore ISI Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI PEN Penumbra $280.77 / +0.9 (+0.32%) 12/16/20 Fly Intel: Top five analyst downgrades 12/16/20 Wells Fargo Penumbra price target lowered to $215 from $265 at Wells Fargo 12/16/20 Canaccord Penumbra price target lowered to $204 from $292 at Canaccord 12/16/20 Citi Citi keeps Buy rating on Penumbra, says recall 'clearning event' PODD Insulet $261.12 / +4.25 (+1.65%) 02/04/21 Piper Sandler Tandem trades at 'significant discount' to Insulet, says Piper Sandler 01/29/21 Piper Sandler Insulet downgraded to Neutral from Overweight at Piper Sandler 12/16/20 Citi Insulet downgraded to Neutral from Buy at Citi 11/05/20 Wells Fargo Insulet price target raised to $266 from $250 at Wells Fargo SHC Sotera Health $26.39 / -0.86 (-3.16%) 01/13/21 Baird Sotera Health initiated with an Outperform at Baird 12/15/20 KeyBanc Sotera Health initiated with an Overweight at KeyBanc 12/15/20 JPMorgan Sotera Health initiated with an Overweight at JPMorgan 12/15/20 Jefferies Sotera Health initiated with a Buy at Jefferies SLQT SelectQuote $29.96 / -0.09 (-0.30%) 02/10/21 Citi SelectQuote price target raised to $34 from $32 at Citi 02/09/21 Evercore ISI SelectQuote price target raised to $38 from $35 at Evercore ISI 02/09/21 Barclays SelectQuote price target raised to $36 from $32 at Barclays 10/06/20 Credit Suisse Walmart entry shows attractiveness of insurance market, says Credit Suisse TECH Bio-Techne $376.78 / +0.05 (+0.01%) 02/23/21 Stifel Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance 02/23/21 Stifel Bio-Techne upgraded to Buy from Hold at Stifel 02/03/21 Craig-Hallum Bio-Techne price target raised to $440 from $352 at Craig-Hallum 02/03/21 Citi Bio-Techne price target raised to $400 from $310 at Citi TNDM TNDM / + 01/21/21 Citi Citi adds Tandem, removes Guardant from 'Value Creators' list 12/15/20 Wells Fargo Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up 12/15/20 Wells Fargo Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 02/09/21 Piper Sandler Zimmer Biomet multiple should move higher into spin, says Piper Sandler 02/08/21 SVB Leerink Zimmer Biomet price target raised to $190 from $185 at SVB Leerink 02/08/21 Wells Fargo Zimmer Biomet price target raised to $176 from $165 at Wells Fargo 02/08/21 Deutsche Bank Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank ZBH TNDM TECH SLQT SHC PODD PEN MTD MDT JNJ HOLX EXAS DXCM DGX BIO ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 02/05/21 Zimmer Biomet reports Q4 adjusted EPS 2.11, consensus $2.06 02/04/21 Notable companies reporting before tomorrow's open 11/06/20 Zimmer Biomet not providing Q4 guidance TNDM TNDM / + 11/05/20 Tandem Diabetes raises FY20 revenue view to $465M-$475M from $450M-$465M 11/05/20 Tandem Diabetes reports Q3 EPS (15c), consensus (10c) TECH Bio-Techne $376.78 / +0.05 (+0.01%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09 SLQT SelectQuote $29.96 / -0.09 (-0.30%) 02/08/21 SelectQuote raises FY21 revenue view to $920M-$940M from $840M-$880M 02/08/21 SelectQuote reports Q2 EPS 55c, consensus 44c 11/05/20 SelectQuote raises FY21 revenue view to $840M-$880M from $775M-$815M 11/05/20 SelectQuote reports Q1 EPS 1c, consensus (4c) SHC Sotera Health $26.39 / -0.86 (-3.16%) 01/11/21 Sotera Health reports preliminary 2020 revenue $817M, consensus $814.05M 01/11/21 Sotera Health reports preliminary Q4 revenue $216M, consensus $206.91M PODD Insulet $261.12 / +4.25 (+1.65%) 02/23/21 Insulet reports Q4 EPS (26c), consensus (4c) 11/04/20 Insulet raises FY20 revenue growth guidance to 20%-21% from 17%-19% 11/04/20 Insulet reports Q3 EPS 17c, consensus 8c PEN Penumbra $280.77 / +0.9 (+0.32%) 02/23/21 Penumbra sees FY21 revenue $675M-$685M, consensus $654.52M 02/23/21 Penumbra reports Q4 EPS 10c, consensus (7c) 01/11/21 Penumbra sees FY20 adjusted revenue $566M-$566.4M, consensus $531.88M 01/11/21 Penumbra sees Q4 adjusted revenue $172.5M-$172.9M, consensus $135.25M MTD Mettler-Toledo $1,110.50 / -24.39 (-2.15%) 02/04/21 Mettler-Toledo sees Q1 adjusted EPS $5.55-$5.70, consensus $5.14 02/04/21 Mettler-Toledo raises FY21 adjusted EPS view to $29.20-$29.80 from $27.50-$28.30 02/04/21 Mettler-Toledo reports Q4 adjusted EPS $9.26, consensus $8.72 11/05/20 Mettler-Toledo sees FY21 adjusted EPS $27.50-$28.30, consensus $26.28 MDT Medtronic $118.01 / +2.26 (+1.95%) 02/23/21 Medtronic reports Q3 EPS $1.29, consensus $1.15 11/24/20 Medtronic reports Q2 EPS $1.02, consensus 80c 10/14/20 Medtronic sees long-term annual organic revenue growth of 5% 08/25/20 Medtronic not providing guidance at this time JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open HOLX Hologic $75.56 / +0.96 (+1.29%) 01/27/21 Hologic sees Q2 adjusted EPS $2.56-$2.68, consensus $2.02 01/27/21 Hologic reports Q1 adjusted EPS $2.86, consensus $2.17 01/27/21 Notable companies reporting after market close 01/08/21 Hologic reports preliminary Q1 revenue $1.61B, consensus $1.38B EXAS Exact Sciences $138.96 / -3.4 (-2.39%) 02/16/21 Exact Sciences reports Q4 EPS ($2.79), consensus (22c) 02/16/21 Notable companies reporting after market close 01/10/21 Exact Sciences reports preliminary Q4 revenue $464.5M-$467.5M, consensus $431.2M 10/27/20 Exact Sciences reports Q3 EPS ($1.46), consensus (52c) DXCM DexCom $406.68 / -5.06 (-1.23%) 02/11/21 DexCom sees FY21 revenue $2.21B-$2.31B, consensus $2.33B 02/11/21 DexCom reports Q4 EPS $3.48, consensus 92c 01/11/21 DexCom sees FY20 revenue $1.93B, consensus $1.91B 01/11/21 DexCom reports preliminary Q4 revenue at least $567M, consensus $550.73M DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) 02/04/21 Quest Diagnostics sees first half adjusted EPS $5.90-$6.90 02/04/21 Quest Diagnostics reports Q4 adjusted EPS $4.48, consensus $4.24 02/03/21 Notable companies reporting before tomorrow's open BIO Bio-Rad $594.35 / -8.99 (-1.49%) 02/11/21 Bio-Rad sees FY21 revenue growth of 4.5%-5.0% 02/11/21 Bio-Rad reports Q4 EPS $4.01, consensus $3.29 12/10/20 Bio-Rad sees FY23 revenue $2.75B-$2.85B 10/29/20 Bio-Rad reports Q3 adjusted EPS $3.00, consensus $1.80 20 Nov 28 May 21 May 13 May PEN MDT JNJ HOLX PEN Penumbra $280.77 / +0.9 (+0.32%) 12/28/20 Penumbra named a short at Marcus Aurelius, says company 'cannot be trusted' 12/08/20 Penumbra tells CNBC short seller claims are 'baseless' 11/10/20 Quintessential Capital issues short report on Penumbra with $55 target 11/10/20 Penumbra named short idea by Quintessential Capital MDT Medtronic $118.01 / +2.26 (+1.95%) 10/01/20 DOJ opens ventilator antitrust probe with Medtronic focus, WSJ reports 09/30/20 DoJ opens ventilator antitrust probe with Medtronic focus, WSJ says JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 02/16/21 South Africa to share AstraZeneca COVID-19 vaccine doses, Reuters reports 02/09/21 J&J CEO says Covid vaccine may be given annually, like the flu, CNBC reports 02/02/21 Johnson & Johnson seeks approval of COVID-19 vaccine in Thailand, Reuters says 01/22/21 J&J director says company could boost vaccine availability by spring, CNBC says HOLX Hologic $75.56 / +0.96 (+1.29%) 02/13/21 Hologic looks cheap, time to buy, Barron's says ZBH SLQT SHC PEN MTD MDT JNJ HOLX EXAS DXCM DGX ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 02/05/21 Fly Intel: Pre-market Movers SLQT SelectQuote $29.96 / -0.09 (-0.30%) 02/08/21 Fly Intel: After-Hours Movers 11/16/20 Fly Intel: What to watch in Walmart's earnings report 09/10/20 Fly Intel: Pre-market Movers 09/09/20 Fly Intel: After-Hours Movers SHC Sotera Health $26.39 / -0.86 (-3.16%) 11/22/20 Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO PEN Penumbra $280.77 / +0.9 (+0.32%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/16/20 Short-seller target Penumbra slides after recall of JET 7 catheters MTD Mettler-Toledo $1,110.50 / -24.39 (-2.15%) 02/04/21 Fly Intel: After-Hours Movers MDT Medtronic $118.01 / +2.26 (+1.95%) 10/08/20 Tesla upgrade, Citi downgrade among today's top calls on Wall Street 08/25/20 Fly Intel: Wall Street's top stories for Tuesday 08/25/20 Fly Intel: Wall Street's top stories at midday 08/25/20 Fly Intel: Pre-market Movers JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 01/29/21 Fly Intel: Wall Street's top stories at midday HOLX Hologic $75.56 / +0.96 (+1.29%) 01/27/21 Fly Intel: After-Hours Movers 11/20/20 Nikola initiation at Loop among today's top calls on Wall Street 08/27/20 Fly Intel: Wall Street's top stories at midday 08/27/20 Abbott Labs jumps after securing FDA approval for $5 COVID-19 test EXAS Exact Sciences $138.96 / -3.4 (-2.39%) 02/16/21 Fly Intel: After-Hours Movers 10/28/20 AMD, Lululemon upgrades among today's top calls on Wall Street 10/27/20 Fly Intel: Wall Street's top stories for Tuesday 10/27/20 Fly Intel: Wall Street's top stories at midday DXCM DexCom $406.68 / -5.06 (-1.23%) 02/11/21 Fly Intel: After-Hours Movers 01/11/21 Fly Intel: Pre-market Movers 10/26/20 Fly Intel: After-Hours Movers 10/02/20 DexCom downgrade, Shake Shack initiation among today's top calls on Wall Street DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) 02/04/21 Fly Intel: Pre-market Movers 12/17/20 AT&T downgrade, Yum! Brands upgrade among today's top calls on Wall Street 12/16/20 Fly Intel: Pre-market Movers 10/26/20 Fly Insider: Selecta, Netflix among week's notable insider trades 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 02/25/21 10th Annual Global Healthcare Virtual Conference 02/25/21 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference 03/01/21 42nd Annual Institutional Investors Virtual Conference 00:00 Today 41st Annual Healthcare Virtual Conference 02/23/21 Medtronic - MDT 02/23/21 Insulet - PODD 02/23/21 Penumbra - PEN 02/24/21 Tandem Diabetes - TNDM 04/20/21 Johnson & Johnson - JNJ 02/23/21 Pathway to Protection 03/08/21 Tandem Diabetes 03/11/21 Hologic Inc 03/11/21 Quest Diagnostics Incorporated ZBH SLQT MDT JNJ HOLX EXAS DGX BIO ZBH Zimmer Biomet $161.82 / +1.47 (+0.92%) 12/29/20 Early notable gainers among liquid option names on December 29th SLQT SelectQuote $29.96 / -0.09 (-0.30%) 02/08/21 SelectQuote options imply 13.0% move in share price post-earnings 01/19/21 Unusual call flow in option market yesterday 01/15/21 SelectQuote call buyer as shares jump MDT Medtronic $118.01 / +2.26 (+1.95%) 02/23/21 Early notable gainers among liquid option names on February 23rd 10/08/20 Unusually active option classes on open October 8th 08/25/20 Early notable gainers among liquid option names on August 25th 08/25/20 Unusually active option classes on open August 25th JNJ Johnson & Johnson $160.50 / -1.265 (-0.78%) 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd HOLX Hologic $75.56 / +0.96 (+1.29%) 02/01/21 Early notable gainers among liquid option names on February 1st 01/08/21 Early notable gainers among liquid option names on January 8th 10/26/20 Early notable gainers among liquid option names on October 26th 09/11/20 Early notable gainers among liquid option names on September 11th EXAS Exact Sciences $138.96 / -3.4 (-2.39%) 10/23/20 EXACT Sciences call volume above normal and directionally bullish DGX Quest Diagnostics $117.46 / +1.24 (+1.07%) 10/23/20 Early notable gainers among liquid option names on October 23rd 10/16/20 Early notable gainers among liquid option names on October 16th BIO Bio-Rad $594.35 / -8.99 (-1.49%) 02/12/21 Early notable gainers among liquid option names on February 12th
Hot Stocks	Bio-Techne, Luminary Therapeutics sign license agreement for us of TcBuster » 07:08 02/23/21 02/23 07:08 02/23/21 07:08 TECH Bio-Techne $376.66 / -13.98 (-3.58%) Bio-Techne announced the… Bio-Techne announced the signing of a license agreement with Luminary Therapeutics for the use of TcBuster for the manufacturing of gene-modified cell therapies. TcBuster is Bio-Techne's proprietary non-viral transposon-based gene delivery system used to advance cell therapy manufacturing. Under the terms of this agreement, Bio-Techne grants Luminary Therapeutics a non-exclusive license for TcBuster. Luminary Therapeutics will use TcBuster in their LMY-920 program, a BAFF-CAR-T product. Luminary Therapeutics plans to file an IND with the FDA later this calendar year. ShowHide Related Items >><< Company News Street Research Earnings Events TECH Bio-Techne $376.66 / -13.98 (-3.58%) 02/08/21 Kantaro Biosciences signs marketing and distribution agreement with Atrys 01/28/21 Bio-Techne announces strategic investment in Eminence 12/02/20 Bio-Techne and Regulus collaborate in biomarker development 11/25/20 Kantaro receives FDA EUA for semi-quantitative COVID-19 antibody test kit TECH Bio-Techne $376.66 / -13.98 (-3.58%) 02/23/21 Stifel Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance 02/23/21 Stifel Bio-Techne upgraded to Buy from Hold at Stifel 02/03/21 Craig-Hallum Bio-Techne price target raised to $440 from $352 at Craig-Hallum 02/03/21 Citi Bio-Techne price target raised to $400 from $310 at Citi TECH Bio-Techne $376.66 / -13.98 (-3.58%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09 02/25/21 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference

Upgrade	Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance » 07:06 02/23/21 02/23 07:06 02/23/21 07:06 TECH Bio-Techne $376.66 / -13.98 (-3.58%) As previously reported,… As previously reported, Stifel analyst Daniel Arias upgraded Bio-Techne to Buy from Hold with a price target of $435, up from $400. The case for "outperformance on the back of top-line excellence looks strong," argues Arias, who thinks the company has several areas of the portfolio that have re-accelerated sharply and also has new drivers that will enter the mix over the next 12 months. He sees the company being "on the verge of being a multi-year 15-20% revenue grower," the analyst added. ShowHide Related Items >><< Company News Street Research Earnings Events TECH Bio-Techne $376.66 / -13.98 (-3.58%) 02/08/21 Kantaro Biosciences signs marketing and distribution agreement with Atrys 01/28/21 Bio-Techne announces strategic investment in Eminence 12/02/20 Bio-Techne and Regulus collaborate in biomarker development 11/25/20 Kantaro receives FDA EUA for semi-quantitative COVID-19 antibody test kit TECH Bio-Techne $376.66 / -13.98 (-3.58%) 02/23/21 Stifel Bio-Techne upgraded to Buy from Hold at Stifel 02/03/21 Craig-Hallum Bio-Techne price target raised to $440 from $352 at Craig-Hallum 02/03/21 Citi Bio-Techne price target raised to $400 from $310 at Citi 01/12/21 Stifel Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel TECH Bio-Techne $376.66 / -13.98 (-3.58%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09 02/25/21 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
Upgrade	Bio-Techne upgraded to Buy from Hold at Stifel » 05:34 02/23/21 02/23 05:34 02/23/21 05:34 TECH Bio-Techne $376.66 / -13.98 (-3.58%) Stifel analyst Daniel… Stifel analyst Daniel Arias upgraded Bio-Techne to Buy from Hold with a $435 price target. ShowHide Related Items >><< Company News Street Research Earnings Events TECH Bio-Techne $376.66 / -13.98 (-3.58%) 02/08/21 Kantaro Biosciences signs marketing and distribution agreement with Atrys 01/28/21 Bio-Techne announces strategic investment in Eminence 12/02/20 Bio-Techne and Regulus collaborate in biomarker development 11/25/20 Kantaro receives FDA EUA for semi-quantitative COVID-19 antibody test kit TECH Bio-Techne $376.66 / -13.98 (-3.58%) 02/03/21 Craig-Hallum Bio-Techne price target raised to $440 from $352 at Craig-Hallum 02/03/21 Citi Bio-Techne price target raised to $400 from $310 at Citi 01/12/21 Stifel Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel 11/09/20 KeyBanc Bio-Techne initiated with a Sector Weight at KeyBanc TECH Bio-Techne $376.66 / -13.98 (-3.58%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09 02/25/21 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
Hot Stocks	Kantaro Biosciences signs marketing and distribution agreement with Atrys » 07:35 02/08/21 02/08 07:35 02/08/21 07:35 TECH Bio-Techne $380.67 / -1.81 (-0.47%) , RNLX Renalytix AI $25.80 / +0.99 (+3.99%) Kantaro Biosciences, a… Kantaro Biosciences, a joint venture between the Mount Sinai Health System and RenalytixAI (RNLX), and manufacturing partner Bio-Techne Corporation (TECH), entered into a marketing and distribution agreement with Atrys Health, a biomedical company dedicated to providing diagnostic services and medical treatments of excellence. Atrys Health will offer COVID-SeroKlir and COVID-SeroIndex, Kantaro's quantitative SARS-CoV-2 IgG antibody test kits, in select European and South American territories, including Spain, Portugal, Colombia, Brazil, Peru and Chile. Atrys Health is a distributor for Kantaro quantitative antibody tests in select European and South American territories.The Kantaro tests have received a CE Mark for detecting the presence and precise level of neutralizing IgG antibodies that are produced as part of the immune response to COVID-19 virus exposure. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Options TECH RNLX TECH Bio-Techne $380.67 / -1.81 (-0.47%) 01/28/21 Bio-Techne announces strategic investment in Eminence 12/02/20 Bio-Techne and Regulus collaborate in biomarker development 11/25/20 Kantaro receives FDA EUA for semi-quantitative COVID-19 antibody test kit 10/28/20 Bio-Techne and Renalytix's Kantaro JV to market COVID-19 testing in UK, Europe RNLX Renalytix AI $25.80 / +0.99 (+3.99%) 02/04/21 Renalytix AI, ASN to co-host virtual Capital Markets Day for kidney Health 11/06/20 Renalytix AI appoints Investec Bank as joint corporate broker TECH RNLX TECH Bio-Techne $380.67 / -1.81 (-0.47%) 02/03/21 Craig-Hallum Bio-Techne price target raised to $440 from $352 at Craig-Hallum 02/03/21 Citi Bio-Techne price target raised to $400 from $310 at Citi 01/12/21 Stifel Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel 11/09/20 KeyBanc Bio-Techne initiated with a Sector Weight at KeyBanc RNLX Renalytix AI $25.80 / +0.99 (+3.99%) 08/11/20 JPMorgan Renalytix AI initiated with a Neutral at JPMorgan 08/11/20 Stifel Renalytix AI initiated with a Buy at Stifel TECH RNLX TECH Bio-Techne $380.67 / -1.81 (-0.47%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09 RNLX Renalytix AI $25.80 / +0.99 (+3.99%) 11/25/20 Renalytix AI reports Q1 EPS (10c) vs. (3c) last year 17 Jul RNLX RNLX Renalytix AI $25.80 / +0.99 (+3.99%) 01/21/21 Eighteen new option listings and one option delisting on January 21st
Recommendations	Bio-Techne price target raised to $440 from $352 at Craig-Hallum » 08:45 02/03/21 02/03 08:45 02/03/21 08:45 TECH Bio-Techne $376.61 / +35.25 (+10.33%) Craig-Hallum analyst… Craig-Hallum analyst Alexander Nowak raised the firm's price target on Bio-Techne to $440 from $352 and keeps a Buy rating on the shares. The analyst notes that the company posted "another impressive quarter," beating the Street's revenue and EPS estimates. ShowHide Related Items >><< Company News Street Research Earnings TECH Bio-Techne $376.61 / +35.25 (+10.33%) 01/28/21 Bio-Techne announces strategic investment in Eminence 12/02/20 Bio-Techne and Regulus collaborate in biomarker development 11/25/20 Kantaro receives FDA EUA for semi-quantitative COVID-19 antibody test kit 10/28/20 Bio-Techne and Renalytix's Kantaro JV to market COVID-19 testing in UK, Europe TECH Bio-Techne $376.61 / +35.25 (+10.33%) 02/03/21 Citi Bio-Techne price target raised to $400 from $310 at Citi 01/12/21 Stifel Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel 11/09/20 KeyBanc Bio-Techne initiated with a Sector Weight at KeyBanc 11/06/20 Baird Bio-Techne price target raised to $320 from $289 at Baird TECH Bio-Techne $376.61 / +35.25 (+10.33%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09 08/04/20 Bio-Techne reports Q4 adj. EPS $1.00, consensus 75c
Recommendations	Bio-Techne price target raised to $400 from $310 at Citi » 06:24 02/03/21 02/03 06:24 02/03/21 06:24 TECH Bio-Techne $376.61 / +35.25 (+10.33%) Citi analyst Patrick… Citi analyst Patrick Donnelly raised the firm's price target on Bio-Techne to $400 from $310 and keeps a Neutral rating on the shares. The company provided a "bullish" near-term outlook on the earnings call, indicating that with the easiest comps of the year upcoming in the second half of fiscal 2021, it should be able to continue its momentum and grow at or above the 15% organic growth posted through the first half, Donnelly tells investors in a research note. ShowHide Related Items >><< Company News Street Research Earnings TECH Bio-Techne $376.61 / +35.25 (+10.33%) 01/28/21 Bio-Techne announces strategic investment in Eminence 12/02/20 Bio-Techne and Regulus collaborate in biomarker development 11/25/20 Kantaro receives FDA EUA for semi-quantitative COVID-19 antibody test kit 10/28/20 Bio-Techne and Renalytix's Kantaro JV to market COVID-19 testing in UK, Europe TECH Bio-Techne $376.61 / +35.25 (+10.33%) 01/12/21 Stifel Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel 11/09/20 KeyBanc Bio-Techne initiated with a Sector Weight at KeyBanc 11/06/20 Baird Bio-Techne price target raised to $320 from $289 at Baird 09/30/20 Atlantic Equities Bio-Techne initiated with an Overweight at Atlantic Equities TECH Bio-Techne $376.61 / +35.25 (+10.33%) 02/02/21 Bio-Techne reports Q2 non-GAAP EPS $1.62, consensus $1.37 11/05/20 Bio-Techne reports Q1 adj. EPS $1.43, consensus $1.09 08/04/20 Bio-Techne reports Q4 adj. EPS $1.00, consensus 75c

On The Fly

News and insights, exclusive to thefly.com

20:25	Notable companies reporting before tomorrow's open»
16:38	JPMorgan downgrades Athenex on 'huge surprise' from FDA»
13:49	Notable companies reporting before tomorrow's open»
13:47	Notable companies reporting after market close»
12:48	Morphic Holding price target raised to $103 from $40 at Wells Fargo»

View all On The Fly Stories »

Upcoming
Events (10)

KMPH	PDUFA Date for KP415
AOSL	Alpha & Omega - AOSL
UEPS	Net 1 UEPS - UEPS
	Microsoft Ignite
	Western Financial Services Virtual Conference
	European Medtech & Services Virtual Conference
MFG ...	2021 Annual Washington Virtual Conference
	Energy & Power Virtual Conference
SAIL ...	Technology, Media & Telecom Virtual Conference
	Global Environmental, Social & Governance Virtual Conference 2021

View all of today’s events »

Today’s
Syndicate (9)

SWTX	Block Trade
KRTX	Secondary
EAF	Spot Secondary
FRC	Spot Secondary
HLNE	Spot Secondary
JELD	Spot Secondary
RDHL	Spot Secondary
SITC	Spot Secondary
WSC	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial